Skip to content
    Tybourne Capital Management logo

    Tybourne Capital Management

    Hong KongFounded 2012
    www.tybournecapital.comLinkedIn
    ConsumerFintechHealthcareMedia & EntertainmentTelecom

    Tybourne Capital Management is an Asia-based global growth investor with a fundamental approach to equity investing across public and private markets. Founded in 2012 by Eashwar Krishnan, the firm focuses on high-growth industries including consumer, financial services, technology, media, telecommunications, and healthcare sectors.

    Average disclosed round size is $141.2M (across 12 rounds with reported amounts).

    Find people at Tybourne Capital Management on Goldilocks AI

    Portfolio

    14

    Fund Size

    $8.6B

    Top Stage

    Series C

    Last 12 Mo

    0

    Team

    BH

    Bosun Hau

    Managing Partner & Co-Founder, Tybourne Strategic Opportunities Fund

    SZ

    Sebastian Zahedi

    Managing Director

    JV

    Jacob Vink

    Investor

    EV

    Eashwar Viswanathan Krishnan

    Portfolio Manager

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    16 investments
    CompanyRoundAmountDate
    SkyCell logoSkyCellSeries D$57MJan 2023
    AAsuene IncSeries B$20MOct 2022
    AAcelyrin, IncSeries C$300MSep 2022
    AAcelyrinSeries C$300MSep 2022
    Kopi Kenangan logoKopi KenanganSeries C$96MDec 2021
    Lunit logoLunitIpo$61MNov 2021
    Amylyx Pharmaceuticals logoAmylyx PharmaceuticalsSeries C—Jan 2021
    PProvivi, Inc.Series C$85MOct 2019
    LianBio logoLianBioUnknown$310M—
    GGlobal Dental ServicesSeries D$50M—
    Cambridge Photon Technology logoCambridge Photon TechnologySeries A——
    Clove Dental logoClove DentalSeries D$50M—
    AAcelyrin, IncSeries B——
    SkyCell AG logoSkyCell AGSeries D$116M—
    AAcelyrinSeries B$250M—
    Wovn Technologies, Inc. logoWovn Technologies, Inc.Unknown——

    Top Co-Investors

    Marshall Wace4 shared
    venBio4 shared
    Cowen Healthcare Investments4 shared
    Westlake Village BioPartners4 shared
    Decheng Capital4 shared
    OrbiMed4 shared
    Surveyor Capital4 shared
    Samsara BioCapital4 shared
    Access Biotechnology3 shared
    Casdin Capital2 shared
    Viking Global Investors2 shared
    Perceptive Advisors2 shared
    M&G Investments2 shared
    Investcorp2 shared
    Qatar Investment Authority2 shared
    Matrix Partners2 shared
    Horizons Ventures1 shared
    Alpha Wave Global1 shared
    B Capital1 shared
    Naver1 shared

    Last updated: 9 September 2026